MetaCap

Apimeds Pharmaceuticals US Inc. Company Profile

NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.60-0.14 (-8.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Apimeds Pharmaceuticals US at a glance

Apimeds Pharmaceuticals US Inc. (NYSE: APUS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Matawan, NJ. The company's shares have traded publicly since 2025. At a market capitalization of $3.0 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001894525, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Apimeds Pharmaceuticals US do?

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Business description based on the company's public filings.

Company information

Legal name
Apimeds Pharmaceuticals US Inc.
Ticker
NYSE: APUS
Industry
Biotechnology: Pharmaceutical Preparations
Headquarters
100 Matawan Rd, Matawan, NJ, United States
Phone
848 201 5010
IPO year
2025
SEC CIK
0001894525
Latest annual report
10-K · May 4, 2026

Companies similar to Apimeds Pharmaceuticals US

APUS peer companies
CompanyPrice% ChgMarket capCompare
JAGXJaguar Health Inc.0.227-30.58%$3.03Mvs APUS
SKYESkye Bioscience Inc.0.70-11.03%$3.10Mvs APUS
GELSGelteq Limited0.2701-3.74%$3.11Mvs APUS
AZTRAzitra Inc0.5168-2.75%$3.13Mvs APUS
MDCXMedicus Pharma Ltd.1.14-2.16%$3.16Mvs APUS
KPRXKiora Pharmaceuticals Inc.0.7202-12.28%$3.19Mvs APUS
NRSNNeuroSense Therapeutics Ltd.1.28+1.59%$3.19Mvs APUS
TRAWTraws Pharma Inc.0.175-23.91%$2.69Mvs APUS

Related